Cargando…

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis

AIMS/INTRODUCTION: Recently, the use of rosiglitazone has been limited or withdrawn from the market as a result of cardiovascular risk. However, theoretically adding rosiglitazone to insulin could help insulin to decrease the glucose level. The present meta-analysis was designed to investigate the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yu, Ma, Delin, Xu, Weijie, Shao, Shiying, Yu, Xuefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296706/ https://www.ncbi.nlm.nih.gov/pubmed/25621136 http://dx.doi.org/10.1111/jdi.12246

Ejemplares similares

Safety and efficacy of rosiglitazone in the elderly diabetic patient
por: Viljoen, Adie, et al.
Publicado: (2009)

Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis
por: Chen, Cai, et al.
Publicado: (2015)

Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality
por: Wilson, Kitchener D., et al.
Publicado: (2008)

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial
por: Florez, H, et al.
Publicado: (2015)

Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease
por: Wang, Chao-Hung, et al.
Publicado: (2006)

Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes
por: Tonoike, Mie, et al.
Publicado: (2018)

Electroacupuncture and Rosiglitazone Combined Therapy as a Means of Treating Insulin Resistance and Type 2 Diabetes Mellitus: A Randomized Controlled Trial
por: Lin, Rong-Tsung, et al.
Publicado: (2013)

Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
por: DeFronzo, Ralph A., et al.
Publicado: (2010)

Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes
por: Li, Juan, et al.
Publicado: (2019)

Association between omega‐3 fatty acids consumption and the risk of type 2 diabetes: A meta‐analysis of cohort studies
por: Chen, Cai, et al.
Publicado: (2017)

Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM
por: Guclu, Metin, et al.
Publicado: (2015)

Candidate genes associated with the effect of rosiglitazone on glycemic control and cardiovascular system in the treatment of type 2 diabetes mellitus
por: Wu, Xiaoli
Publicado: (2019)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
por: Galindo, Demi C., et al.
Publicado: (2020)

Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
por: Xu, James, et al.
Publicado: (2017)

Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
por: Han, Eugene, et al.
Publicado: (2016)

Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats
por: Kavak, Servet, et al.
Publicado: (2012)

Improvement of abnormal liver enzymes after rosiglitazone treatment in Chinese type 2 diabetes
por: Zheng, Jing-Quan, et al.
Publicado: (2012)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
por: Rao, Ravi Prakash, et al.
Publicado: (2011)

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)

Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics
por: Tahiri, Youssef, et al.
Publicado: (2007)

Long-Term Effects of Rosiglitazone on the Progressive Decline in Renal Function in Patients With Type 2 Diabetes
por: Kim, Mee Kyoung, et al.
Publicado: (2009)

Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials
por: Liu, Ying, et al.
Publicado: (2022)

Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes
por: Zhang, Zeqing, et al.
Publicado: (2017)

Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria
por: Varo, Rosauro, et al.
Publicado: (2017)

Rosiglitazone Prior Authorization Safety Policy: A Cohort Study
por: Starner, Catherine I., et al.
Publicado: (2012)

Simpson's paradox visualized: The example of the Rosiglitazone meta-analysis
por: Rücker, Gerta, et al.
Publicado: (2008)

Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
por: Sato, Seiji, et al.
Publicado: (2015)

Adding Pioglitazone to Insulin Containing Regimens in Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Clar, Christine, et al.
Publicado: (2009)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
por: Ahmann, Andrew
Publicado: (2015)

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
por: Rahman, Sayeeda, et al.
Publicado: (2009)

Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT
por: Kahn, Steven E., et al.
Publicado: (2011)

Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis
por: Sardone, Laura D., et al.
Publicado: (2011)

Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
por: Rasgon, Natalie L., et al.
Publicado: (2010)

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes1
por: Home, P D, et al.
Publicado: (2007)

Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment
por: Abbatecola, Angela M., et al.
Publicado: (2010)

Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients
por: Tseng, Chin-Hsiao
Publicado: (2019)

Analysis of cardiovascular risks for erectile dysfunction in Chinese patients with type 2 diabetes mellitus lacking clinical symptoms of cardiovascular diseases
por: Yuan, Penghui, et al.
Publicado: (2020)

Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes
por: Shankar, R Ravi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0vs8c4q8pko7tek04cf9tifdsb